Laura James, MD, director of the Translational Research Institute and vice chancellor for Clinical and Translational Research at UAMS, will be the featured speaker at 2 p.m. Wednesday, April 9, for the Health Sciences Entrepreneurship Grand Rounds. 

James, who is co-founder of the rapid acetaminophen-induced liver injury testing company Acetaminophen Toxicity Diagnostics, will speak about “Creating a New Diagnostic Test: Translational Science Principles in Action.” 

Join us at the Winthrop P. Rockefeller Cancer Institute, 10th Floor, Betsy Blass Conference Room, Room 10014. 

The UAMS community and public are welcome to attend. 

HSE Grand Rounds are sponsored by the Translational Research Institute’s Health Sciences Innovation and Entrepreneurship Postdoctoral Training Program and BioVentures LLC.